Advertisement

Reactions Weekly

, Volume 1597, Issue 1, pp 1–1 | Cite as

FDA adding HF warnings to labels of alogliptin, saxagliptin

News item
  • 82 Downloads

Reference

  1. FDA. FDA Drug Safety Communication: FDA adds warnings about heart failure risk to labels of type 2 diabetes medicines containing saxagliptin and alogliptin. Internet Document : 5 Apr 2016. Available from: URL: http://www.fda.gov/Drugs/DrugSafety/ucm486096.htm

Copyright information

© Springer International Publishing Switzerland 2016

Personalised recommendations